Nanobiotix(NBTX) - 2023 Q3 - Earnings Call Transcript

Laurent Levy Hi. Thank you for taking my question. I had one for the pancreatic cancer study. How comparable are the baseline characteristics of the patients into previous MD studies? And the patients in the ongoing Phase 1, for instance, in terms of level of CA19-9 at diagnosis? And could you give us the amplitude of reduction of that biomarker levels observed in your study? the RP2D. So, the enrollment continues to be good in this trial. It's just slightly delayed versus what was initially planned. But al ...